BRTX Earnings — BioRestorative Therapies, Inc. Common Stock (NV) Post-ER Performance | BigEarnings
BRTX — BioRestorative Therapies, Inc. Common Stock (NV)
XNAS · Healthcare · Biotechnology
Price$0.48
Market Cap$12.2M
P/E—
52W Range— – —
Next Earnings2026-08-11
About BioRestorative Therapies, Inc. Common Stock (NV)
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
